Synergistic effects of C-C chemokine receptor 2 inhibitor and transforming growth factor-β type I receptor kinase inhibitor combination in metabolic dysfunction-associated steatohepatitis
- Metab.-Clin. Exp., Available online 8 June 2025, 156323 | https://doi.org/10.1016/j.metabol.2025.156323